Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin versus cefazolin regimens for suspected late-onset sepsis in very preterm infants
ACTRN12618000073202Phase 4Completed
- Sponsor
- John Hunter Hospital
- Start
- Apr 2018
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin, vancomycin and gentamicin in late-onset neonatal sepsis (LONS), sponsored by John Hunter Hospital. Started Apr 2018; status: completed.
02
Drugs
cefazolinvancomycingentamicin
03
Conditions
late-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on ACTRN12618000073202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000073202.